Hepatitis C Virus-related chronic liver disease in elderly patients: An Italian cross-sectional study

Journal of Viral Hepatitis

Volumn 17, Issue 5, 2010, Pages 360-366

  Gramenzi, A ^a   Conti, F ^a   Felline, F ^a,b   Cursaro, C ^a,b   Riili, A ^a   Salerno, M ^b   Gitto, S ^a   Micco, L ^a   Scuteri, A ^a   Andreone, P ^a,b   Bernardi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ambulatorio Epatologia   (Italy)

Author keywords

Antiviral treatment; Chronic hepatitis C; Cirrhosis; Elderly; Hepatocellular carcinoma

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HEPATIC ENCEPHALOPATHY; HEPATITIS C VIRUS; HEPATORENAL SYNDROME; HUMAN; ITALY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PORTAL HYPERTENSION; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; ITALY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RNA, VIRAL; YOUNG ADULT;

EID: 77949755595     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01189.x     Document Type: Article

References (25)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005 5 : 558 567.
2. Sagnelli E, Stroffolini T, Mele A et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9997 cases. J Med Virol 2005 75 : 522 527.
3. Fagiuoli S, Mirante VG, Pompili M et al. Liver transplantation: the Italian experience. Dig Liver Dis 2002 34 : 640 648.
4. Guadagnino V, Stroffolini T, Rapicetta M et al. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population. A community-based survey in Southern Italy. Hepatology 1997 26 : 1006 1011.
5. Bellentani S, Pozzato G, Saccoccio G et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population. Report from the Dionysos Study. Gut 1999 44 : 874 880.
6. Maio G, D'Argenio P, Stroffolini T et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol 2000 33 : 116 120.
7. Dubois F, Desenclos JC, Mariotte N et al. Hepatitis C in a French population based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997 25 : 1490 1496.
8. Dominguez A, Bruguera M, Vidal J et al. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 2001 65 : 688 693.
9. Okayama A, Stuver SO, Tabor E et al. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat 2002 9 : 43 51.
10. Di Stefano R, Stroffolini T, Ferraro D et al. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. J Med Virol 2002 67 : 339 344.
11. Pendino GM, Mariano A, Surace P et al. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 2005 41 : 1151 1159.
12. Stroffolini T, Sagnelli E, Mariano A et al. Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6999 cases. J Viral Hepat 2006 13 : 351 354.
13. Fabris P, Baldo V, Baldovin T et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol 2008 42 : 527 532.
14. Watson JP, Brind AM, Chapman CE et al. Hepatitis C virus: epidemiology, and genotypes in the north east of England. Gut 1996 38 : 269 276.
15. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997 349 : 852 832.
16. Thabut D, Le Calvez S, Thibault V et al. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? Am J Gastroenterol 2006 101 : 1260 1267.
17. Ikeda K, Saitoh S, Suzuki Y et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2,215 patients. J Hepatol 1998 28 : 930 938.
18. Bellentani S, Saccoccio G, Costa G et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997 41 : 845 850.
19. Gaiani S, Gramantieri L, Venturoli N et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997 27 : 979 985.
20. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208 1236.
21. Ansaldi F, Bruzzone B, Salmaso S et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 2005 76 : 327 332.
22. Poynard T, Ratziu V, Charlotte F et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001 34 : 730 739.
23. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002. Hepatology 2002 36 (Suppl 1 S3 S20.
24. Mindikoglu AL, Miller RR. Hepatitis C in the elderly: epidemiology, natural history and treatment. Clin Gastroenterol Hepatol 2009 7 : 128 134.
25. Tsui JI, Currie S, Shen H et al. Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 study. Dig Dis Sci 2008 53 : 809 814.